| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/25/2009 | CN101391066A Traditional Chinese medicine decoction for treating psoriasis |
| 03/25/2009 | CN101391047A Traditional Chinese medicine preparation for treating trichonosis |
| 03/25/2009 | CN101391039A Traditional Chinese medicine ointment for treating burn and preparation method thereof |
| 03/25/2009 | CN101391035A Oral traditional Chinese medicine preparation for treating psoriasis |
| 03/25/2009 | CN101391025A Anti-radiation preparation and production technique thereof |
| 03/25/2009 | CN101391013A Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| 03/25/2009 | CN101391010A Traditional Chinese medicine for treating wound |
| 03/25/2009 | CN101391000A External medicine composition for treating the eczema and preparation method thereof |
| 03/25/2009 | CN101390996A External medicine for quickly treating burn |
| 03/25/2009 | CN101390993A Traditional Chinese medicine for treating diabetic foot |
| 03/25/2009 | CN101390990A Traditional Chinese medicine composition for preventing or treating human genitals disease |
| 03/25/2009 | CN101390985A Traditional Chinese medicine for treating diabetes acral necrosis |
| 03/25/2009 | CN101390983A External Chinese herbal medicine composition for treating poisoned sore |
| 03/25/2009 | CN101390980A External medicine for treating skin disease and preparation method thereof |
| 03/25/2009 | CN101390959A Disinfector for treating nasal vestibule, dryness of nasal cavity and skin burn and scald |
| 03/25/2009 | CN101390958A Huidouba traditional Chinese medicine composite preparation for treating wound, cut trauma, scald and burn |
| 03/25/2009 | CN101390882A Heidouba extract and preparation method and pharmaceutical use thereof |
| 03/25/2009 | CN101390863A Tinea corporis itching-relieving tincture formulation and manufacture method thereof |
| 03/25/2009 | CN101390862A Medicine composition containing mizolastine and preparation method thereof |
| 03/25/2009 | CN101390860A Desloratadine syrup and preparation method thereof |
| 03/25/2009 | CN101390852A Melanogenesis inhibitor and skin preparation containing the same |
| 03/25/2009 | CN101390830A Anarexol cream and preparation method thereof |
| 03/25/2009 | CN101390815A Topical use of thiazolidine derivatives against the consequences of oxidising stress of the skin |
| 03/25/2009 | CN101390551A Notoginseng flower ecchymosis removing instant tea |
| 03/25/2009 | CN101390550A Notoginseng flower ecchymosis removing bagged tea |
| 03/25/2009 | CN100471871C Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/25/2009 | CN100471518C Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel |
| 03/25/2009 | CN100471514C External use preparation for treating vulnus slow agglutination and its preparation method |
| 03/25/2009 | CN100471506C Pharmaceutical composition for treating white lesions of vulva, formulation and preparation process thereof |
| 03/25/2009 | CN100471502C Composition for cell proliferation |
| 03/25/2009 | CN100471499C Physical bacteria resisting net liquid of human body and the producing technique |
| 03/25/2009 | CN100471495C Fumaric acid-ketotifen dispersion tablet and its prepn process |
| 03/25/2009 | CN100471489C Soft capsule containing Lamiophlomis rotata Kudo. root extract |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507750 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507719 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
| 03/24/2009 | US7507712 NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/19/2009 | WO2009036108A1 Methods and compositions for inhibiting vascular leakage |
| 03/19/2009 | WO2009035174A1 Composition for treating or preventing atopic dermatitis comprising poly-gamma-glutamic acid |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034604A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/19/2009 | WO2009034537A2 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid |
| 03/19/2009 | WO2009034325A1 Isoflavone formulation |
| 03/19/2009 | WO2009034130A1 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivatives that can be used to functionalize chitosan. |
| 03/19/2009 | WO2009033808A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033764A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033737A2 Use of gluten exorphin c : as a therapeutic agent |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008152226A3 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 03/19/2009 | WO2008116157A3 Mesenchymal stem cells and uses therefor |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076170 Mixture of organic peroxide such as benzoyl peroxide and antioxidant such as butylated hydroxyltoluene; shelf life, storage stability; skin disorders, acne agents; cosmetics |
| 03/19/2009 | US20090076140 Pharmaceutical compositions containing sulphonic acid derivatives |
| 03/19/2009 | US20090076037 Bicyclic pyrimidine kinase inhibitors |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075958 Clobetasol propionate shampoos for the treatment of seborrheic dermatitis of the scalp |
| 03/19/2009 | US20090075956 Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3 |
| 03/19/2009 | US20090075946 Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 03/19/2009 | US20090075916 Use of Macrolide Derivatives for Treating Acne |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075906 Oligopeptides and compositions containing the oligopeptides |
| 03/19/2009 | US20090075891 Methods and dressings for sealing internal injuries |
| 03/19/2009 | US20090075373 Neural progenitor cells derived from embryonic stem cells |
| 03/19/2009 | US20090074888 Stable cleanser compositions containing sulfur |
| 03/19/2009 | US20090074880 Method for oxygen treatment of intact skin |
| 03/19/2009 | US20090074879 Wound-Healing Composition |
| 03/19/2009 | US20090074868 Photoinitiated tissue filler |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074850 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |
| 03/19/2009 | US20090074823 Self Tanning Cosmetic |
| 03/19/2009 | US20090074735 Topical product containing sacrificial material for neutralizing free radicals |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | US20090074707 Shaped body and method for production of said body |
| 03/19/2009 | US20090074691 Topical Delivery System for Antiaging and Skin Whitening Agents |
| 03/19/2009 | DE102007044202A1 Composition, useful for wound treatment, preferably poor or non-healing open wounds in humans, comprises hyaluronic acid, urea, and colloidal silver |
| 03/19/2009 | CA2698980A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698864A1 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivatives that can be used to functionalize chitosan |
| 03/19/2009 | CA2698831A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2697756A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036882A1 Zwitterionic connections and their use |
| 03/18/2009 | EP2036565A1 Preparation for external application to skin containing triterpenic acid |